Frequency Electronics Inc: Form 10-Q for the period ended Jan 31, 2018
Filed with the SEC on Mar 19, 2018 and accepted by EDGAR at Mar 19, 2018, 15:12 ET.
Management's discussion and analysis
As filed, 24,398 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:
The statements in this quarterly report on Form 10-Q regarding future earnings and operations and other statements relating to the future constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1933 or the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “could,” “should,” “would,” “anticipate,” “estimate,” “expect,” “project,” “intend,” “objective,” “seek,” “strive,” “might,” “likely result,” “build,” “grow,” “plan,” “goal,” “expand,” “position,” or similar words, or the negatives of these words, or similar terminology, identify forward-looking statements. All statements by the Company that address activities, events or developments that the Company expects or anticipates will occur in the future, including all statements by the Company regarding its expected financial position, revenues, cash flows and other operating results, business position, legal proceedings or similar matters, are forward-looking statements. These statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties, and a number of factors could cause the Company’s actual results to differ materially from those expressed in the forward-looking statements referred to above. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company’s products in the marketplace, competitive factors, new products and technological changes, product prices and raw material costs, dependence upon third-party vendors, competitive developments, changes in manufacturing and transportation costs, changes in contractual terms, the availability of capital, and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which relate only to events as of the date on which the statements are made and which reflect management’s analysis, judgments, belief, or expectation only as of such date. By making these forward-looking statements, the Company undertakes no obligation to update these statements after the date such statement was first made.
Critical Accounting Policies and Estimates
The Company’s significant accounting policies are described in Note 1 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2017, filed on July 31, 2017. The Company believes its most critical accounting policies to be the recognition of revenue and costs on production contracts and the valuation of inventory. Each of these areas requires the Company to make use of reasoned estimates including estimating the cost to complete a contract, the realizable value of its inventory or the market value of its products. Changes in estimates can have a material impact on the Company’s financial position and results of operations.
Revenue Recognition
Revenues under larger, long-term contracts which generally require billings based on achievement of milestones rather than delivery of product, are reported in operating results using the percentage of completion method. On fixed-price contracts, which are typical for commercial and U.S. Government satellite programs and other long-term U.S. Government projects, and which require initial design and development of the product, revenue is recognized on the cost-to-cost method. Under this method, revenue is recorded based upon the ratio that incurred costs bear to total estimated contract costs with related cost of sales recorded as the costs are incurred. Each month management reviews estimated contract costs through a process of aggregating actual costs incurred and estimating additional costs to completion based upon the current available information and status of the contract. The effect of any change in the estimated gross margin percentage for a contract is reflected in revenues in the period in which the change is known. Provisions for the full amount of anticipated losses on contracts are made in the period in which they become determinable.
On production-type orders, revenue is recorded as units are delivered with the related cost of sales recognized on each shipment based upon a percentage of estimated final program costs.
Changes in job performance on long-term contracts and production-type orders may result in revisions to costs and income and are recognized in the period in which revisions are determined to be required. Provisions for anticipated losses on customer orders are made in the period in which they become determinable.
For customer orders in the Company’s FEI-Zyfer segment or smaller contracts or orders in the FEI-NY segment, sales of products and services to customers are reported in operating results based upon (i) shipment of the product or (ii) performance of the services pursuant to terms of the customer order. When payment is contingent upon customer acceptance of the installed system, revenue is deferred until such acceptance is received and installation completed.
Costs and Expenses
Contract costs include all direct material, direct labor costs, manufacturing overhead and other direct costs related to contract performance. Selling, general and administrative costs are expensed as incurred.
Inventory
In accordance with industry practice, inventoried costs contain amounts relating to contracts and programs with long production cycles, a portion of which will not be realized within one year. Inventory write downs are established for slow-moving, obsolete items and costs incurred on programs for which production-level orders cannot be determined as probable. Such write downs are based upon management’s experience and expectations for future business. Any changes arising from revised expectations are reflected in cost of sales in the period the revision is made.
Marketable Securities
All of the Company’s investments in marketable securities are Level 1 securities which trade on public markets and have current prices that are readily available. In general, investments in fixed income securities are only in the commercial paper of financially sound corporations or the bonds of U.S. Government agencies. Although the value of such investments may fluctuate significantly based on economic factors, the Company’s own financial strength enables it to wait for the securities to either recover their value or to mature such that any interim unrealized gains or losses are deemed to be temporary.
RESULTS OF OPERATIONS
The table below sets forth for the respective periods of fiscal years 2018 and 2017 (which end on April 30, 2018 and 2017, respectively) the percentage of consolidated revenues represented by certain items in the Company’s consolidated statements of operations:
| Revenues | Nine months Periods ended January 31, 2018 | 2017 | Three months 2018 | 2017 |
|---|---|---|---|---|
| FEI-NY | 69.5% | 79.0% | 61.0% | 83.1% |
| FEI-Zyfer | 38.8 | 27.5 | 42.7 | 25.3 |
| Less intersegment revenues | (8.3) | (6.5) | (3.7) | (8.4) |
| 100.0 | 100.0 | 100.0 | 100.0 | |
| Cost of revenues | 87.9 | 68.6 | 127.0 | 71.3 |
| Gross margin | 12.1 | 31.4 | (27.0) | 28.7 |
| Selling and administrative expenses | 24.4 | 24.6 | 26.0 | 24.9 |
| Research and development expenses | 15.9 | 14.0 | 16.2 | 11.7 |
| Operating loss | (28.2) | (7.2) | (69.2) | (7.9) |
| Other income, net | 3.7 | 0.9 | 0.5 | 0.8 |
| Provision (benefit) for income taxes | 8.6 | (4.0) | 27.0 | (10.4) |
| (Loss) from continued operations | (33.1) | (2.3) | (95.7) | 3.3 |
| (Loss) from discontinued operations, net assets | (2.2) | (1.7) | (2.7) | (0.3) |
| Net (loss) income | (35.3)% | (4.0)% | (98.4)% | 3.0% |
16
Revenues
| Segment | Nine months Periods ended January 31, 2018 | 2017 | Change | Three months 2018 | 2017 | Change | ||
|---|---|---|---|---|---|---|---|---|
| FEI-NY | $22,184 | $27,176 | $(4,992) | (18.4)% | $6,444 | $9,461 | $(3,017) | (31.9)% |
| FEI-Zyfer | 12,378 | 9,473 | 2,905 | 30.7 | 4,514 | 2,877 | 1,637 | 56.9 |
| Intersegment revenues | (2,630) | (2,238) | (392) | 17.6 | (386) | (955) | 569 | (59.6) |
| $31,932 | $34,411 | $(2,479) | (7.2)% | $10,572 | $11,383 | $(811) | (7.1)% |
For the nine months ended January 31, 2018, revenues from commercial and U.S. Government satellite programs decreased approximately $5.4 million over the same period of fiscal year 2017, and accounted for approximately 36% of consolidated revenues compared to approximately 49% in fiscal 2017. Revenues on these contracts are recognized primarily under the percentage of completion method. Revenues from the satellite market are recorded in the FEI-NY segment. Revenues from non-space U.S. Government/Department of Defense (“DOD”) customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, increased $1.0 million over the same period of fiscal 2017, and accounted for approximately 44% of consolidated revenues compared to approximately 37% in fiscal 2017. Other commercial and industrial revenues in the fiscal year 2018 period accounted for approximately 20% of consolidated revenues compared to 14% in the prior year. Intersegment revenues are eliminated in consolidation.
For the three months ended January 31, 2018 revenues from commercial and U.S. Government satellite programs decreased approximately $3.8 million over the same period of fiscal year 2017, and accounted for approximately 23% of consolidated revenues compared to approximately 55% in fiscal 2017. Revenues from non-space U.S. Government/DOD customers, which are recorded in both the FEI-NY and FEI-Zyfer segments, increased $2.3 million over the same period of fiscal 2017, and accounted for approximately 59% of consolidated revenues compared to approximately 34% in fiscal 2017. Other commercial and industrial revenues for the three months ended January 31, 2017 accounted for approximately 18% of consolidated revenues compared to 11% in the prior year.
Based on current backlog, satellite payload revenue for FY2018 is expected to be lower when compared to FY2017, both in total revenue and as a percent of overall revenue. The Company anticipates a significant increase in satellite related bookings and accordingly, with increasing revenues to follow in the coming fiscal year. For the foreseeable future satellite payloads will continue to be a major business area for the Company and represent a significant portion of the company’s overall revenue. Revenues from non-space programs are also anticipated to increase in the coming fiscal year as a result of bids either in progress or from proposals previously submitted.
Gross margin
| Nine months Periods ended January 31, 2018 | 2017 | Change | Three months 2018 | 2017 | Change | |||
|---|---|---|---|---|---|---|---|---|
| $3,872 | $10,821 | $(6,949) | (64.2)% | $(2,852) | $3,267 | $(6,119) | (187.3)% | |
| GM Rate | 12.1% | 31.4% | (27.0%) | 28.7% |
For the nine and three month period ended January 31, 2017 gross margin and gross margin rate decreased over the same period in fiscal 2017. The gross margin and gross margin rate decrease is primarily due to a $5.0 million inventory write downs, lower revenues, increased repair costs and unabsorbed manufacturing overhead costs.
Selling and administrative expenses
Periods ended January 31,
| Nine months 2018 | 2017 | Change | Three months 2018 | 2017 | Change | ||
|---|---|---|---|---|---|---|---|
| $7,796 | $8,483 | $(687) | (8.1)% | $2,749 | $2,834 | $(85) | (3.0)% |
For the nine months ended January 31, 2018 and 2017, selling and administrative (“SG&A”) expenses were approximately 24% and 25%, respectively, of consolidated revenues. For the three months periods ended January 31, 2018 and 2017, SG&A expenses were approximately 26% and 25% respectively, of consolidated revenues. The majority of the reduction occurred in corporate deferred compensation expense, professional fees, and stock option expense.
Research and development expense
Periods ended January 31,
| Nine months 2018 | 2017 | Change | Three months 2018 | 2017 | Change | ||
|---|---|---|---|---|---|---|---|
| $5,071 | $4,832 | $239 | 4.9% | $1,708 | $1,337 | $371 | 27.7% |
Research and development (“R&D”) expenditures represent investments intended to keep the Company’s products at the leading edge of time and frequency technology and enhance future competitiveness. The R&D rate for the nine month period ending January 31, 2018 was 16% compared to 14% of sales for the same period of the previous fiscal year. The R&D rate for the three month period ending January 31, 2018 was 16% compared to 12% of sales for the same period of the previous fiscal year. The Company expects the level of activity related to R&D to continue through the current year and beyond to address new large opportunities in secure communications/command and control applications, next generation satellite payload product and additional DOD and commercial markets.
Operating loss
Periods ended January 31,
| Nine months 2018 | 2017 | Change | Three months 2018 | 2017 | Change | ||
|---|---|---|---|---|---|---|---|
| $(8,995) | $(2,494) | $(6,501) | 260.7% | $(7,309) | $(904) | $(6,405) | 708.5% |
The Company reported approximately $8.3 million of non-cash charges to earnings compared to $3.8 million of non-cash charges, during the nine months ended January 31, 2018 and 2017 respectively. The nine and three month periods ending January 31, 2018 include a $5.0 million inventory write down. The Company recorded decreased revenue, gross margin, and gross margin rate in the three months ending January 31, 2018 leading to increased losses for the nine months ending January 31, 2018 compared to the same periods of the preceding fiscal year.
Other income
| Nine months Periods ended January 31, 2018 | 2017 | Change | Three months 2018 | 2017 | Change | |||
|---|---|---|---|---|---|---|---|---|
| Investment income | $1,236 | $387 | $849 | 219.4% | $68 | $108 | $(40) | (37.0)% |
| Interest expense | (61) | (128) | 67 | (52.3)% | (19) | (61) | 42 | (68.9)% |
| Other income, net | 4 | 50 | (46) | (92.0)% | 1 | 49 | (48) | (98.0)% |
| $1,179 | $309 | $870 | 281.6% | $50 | $96 | $(46) | (47.9)% |
Investment income is derived primarily from the Company’s holdings of marketable securities. Earnings on these securities may vary based on fluctuating interest rates, dividend payout levels, and the timing of purchases or sales of securities. For the three months ending January 31, 2018 investment income was lower than in the same period of fiscal year 2017, mainly due to in the quarter ending July 31, 2017 the Company divested of all its holdings in equities securities in its investment account, which were converted to cash. The Company has re-invested approximately $4.9 million of the cash generated from the sale of equities into fixed income securities. As a result, the Company recorded gains of approximately $1.0 million during the three months ended July 31, 2017 as compared to no gain or loss in the same period of fiscal year 2017.
The decrease in interest expense for the nine months ended January 31, 2017 compared to the same period of fiscal year 2017 is the result of there being no credit line borrowings during the nine months ending January 31, 2017.
Income tax (benefit)
Periods ended January 31,
| Nine months 2018 | 2017 | Change | Three months 2018 | 2017 | Change | ||
|---|---|---|---|---|---|---|---|
| $2,750 | $(1,392) | $4,142 | NM% | $2,848 | $(1,188) | $4,036 | NM% |
| Effective tax rate on pre-tax book income: | |||||||
| (35.2)% | 63.7% | (39.2)% | 147% |
We have recorded a provisional reduction to our U.S. deferred tax assets to reflect the new U.S. federal corporate tax rate. As a result, income tax expense for the three months ended January 31, 2018 includes a discrete income tax expense of approximately $4.8 million for the reduction in our net deferred tax assets.
The effective tax rate for the nine months ended January 31,2018 was (35.2) % compared to 63.7% in the nine months ended January 31, 2017. For the three months ended January 31, 2018 and 2017, the effective tax rates were (39.2) % and 147%, respectively. The current year effective tax rate primarily reflects the impact of the TCJA, deductible permanent differences and R&D credits included in the computation of U.S. federal and state income taxes.
The change in the effective tax rates in the nine and three months ended January 31, 2018 compared to prior periods is primarily due to changes in the earnings mix between U.S. and non-domestic operations, and discrete deferred income tax provisions related to the enactment of the TCJA and stock compensation in connection with the adoption of ASU 2016-09 in the first quarter of fiscal 2018. The new guidance requires all of the tax effects related to stock compensation be recorded discretely through income tax expense. Consequently, for the nine months ended January 31, 2018, the Company recorded a continuing operations income tax provision of $2,750, which includes a current year tax benefit of $2,255 which is reduced by a discrete income tax provision of $5,005. For the three months ended January 31, 2018, the Company recorded an income tax provision of $2,848, which includes a current tax benefit of $2,085 which is reduced by a discrete income tax provision of $4,933.
Discontinued Operations
| Nine months Periods ended January 31, 2018 | 2017 | Change | Three months 2018 | 2017 | Change | |||
|---|---|---|---|---|---|---|---|---|
| Net Loss | $(697) | $(599) | $(98) | 16.4% | $(289) | $(42) | $(247) | NM% |
The above table represents the net loss for the Gillam segment accounted for as discontinued operations as presented in Note B to the financial statements. For the 9 months ended January 31, 2018, as compared to the same periods of fiscal year 2017, gross margin decreased approximately 18%. SG&A expenses and R&D expenses decreased by approximately $126,000 and $19,000 respectively, compared to the prior fiscal year.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s balance sheet continues to reflect a strong working capital position of $53.9 million at January 31, 2018 and $61.7 million at April 30, 2017. Included in working capital at January 31, 2018 and April 30 2017, is $13.2 million and $10.0 million, respectively, consisting of cash, cash equivalents, and marketable securities. The Company’s current ratio at January 31, 2018 is 7.1 to 1.
Cash provided by operations for the nine months ended January 31, 2018 were $2.8 million compared to $1.5 million in the comparable fiscal year 2017 period. The increase cash flow in the fiscal year 2018 period resulted primarily from an increase in accounts receivable collections, compared to the balances as of the end of the previous fiscal year. For the nine-month periods ended January 31, 2018 and 2017, the Company incurred approximately $8.3 million and $3.8 million, respectively, of non-cash operating expenses including depreciation and amortization, inventory reserve adjustments, accruals for employee benefit programs and gain on sale of marketable securities.
Net cash provided by investing activities for the nine months ended January 31, 2018, was $0.5 million compared to $85,000 in the same period of fiscal year 2017. During the fiscal year 2018 period, marketable securities were sold or redeemed in the amount of $6.5 million compared to $3.9 million of such redemptions during the fiscal year 2017 period. For the fiscal year 2018, $5.0 million of marketable securities were purchased. There were no marketable securities purchased for the same period in 2017. In the nine months ended January 31, 2018 and 2017, the Company acquired property, plant and equipment in the amount of approximately $1.0 million and $3.7 million, respectively. The Company may continue to invest cash equivalents as dictated by its investment and acquisition strategies.
Net cash provided by financing activities for the nine months ended January 31, 2018 and 2017 was $1,000 compared to approximately $6.0 million used in financing activities. During the three months ended January 31, 2017, the Company repaid the Note payable of $6 million related to the Line of Credit with JPMorgan that has subsequently been terminated.
The Company has been authorized by its Board of Directors to repurchase up to $5 million worth of shares of its common stock for treasury whenever appropriate opportunities arise but it has neither a formal repurchase plan nor commitments to purchase additional shares in the future. As of January 31, 2018, the Company has repurchased approximately $4 million of its common stock out of the $5 million authorization. For the nine months ended January 31, 2018 and 2017, there were no repurchase of shares.
The Company will continue to expend resources to develop, improve and acquire products for space applications, guidance and targeting systems, and communication systems which management believes will result in future growth and profitability. During fiscal year 2017, the Company secured partial customer funding for a portion of its R&D efforts. The customer funds received in connection therewith appear in revenues and are not included in R&D expenses. For fiscal year 2018, the Company anticipates securing additional customer funding for a portion of its research and development activities, and will allocate internal funds depending on market conditions and identification of new opportunities as in fiscal year 2017. The Company expects internally generated cash will be adequate to fund these development efforts. The Company may also pursue acquisitions to expand its range of products and may use internally generated cash and external funding in connection with such acquisitions.
As of January 31, 2018, the Company’s consolidated funded backlog is approximately $16 million compared to $28 million at April 30, 2017, the end of fiscal year 2017. Approximately 80% of this backlog is expected to be realized in the next twelve months. Included in the backlog at January 31, 2018 is approximately $7.6 million under cost-plus-fee contracts which the Company believes represent firm commitments from its customers for which the Company has not received full funding to-date. The Company excludes from backlog any contracts or awards for which it has not received authorization to proceed and on fixed price contracts excludes any unfunded portion. The Company expects these contracts to become fully funded over time and will add to its backlog at that time.
The Company believes that its liquidity is adequate to meet its operating and investment needs through at least March 19, 2019 and the foreseeable future.
Based upon the Company’s decision to sell its Gillam business and the associated presentation as Discontinued Operations, the Company believes that the effect on cash flow will be neutral. However, it is expected to have a positive cash effect when the intended sale is concluded. The Company is in active negotiation, with a potential foreign buyer, with a view toward completion of a transaction before April 30, 2018.
The Company’s international business is subject to changes in demand or pricing resulting from fluctuations in currency exchange rates, primarily in the Euro to U.S. Dollar exchange rate and in the Chinese Renminbi to U.S. Dollar exchange rate.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements, other than operating leases, that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Controls and procedures
As filed, 1,729 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s chief executive officer and chief financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based on their evaluation, the Company’s chief executive officer and chief financial officer have concluded that, as of January 31, 2018, the Company’s disclosure controls and procedures were effective to ensure that information relating to the Company, including its consolidated subsidiaries, required to be included in its reports that it filed or submitted under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
Changes in Internal Control Over Financial Reporting. There were no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended January 31, 2018 to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-11-01 to 2018-01-31 | $10.6m | us-gaap:Revenues |
| Revenue | 9 months2017-05-01 to 2018-01-31 | $31.9m | us-gaap:Revenues |
| Cost of revenue | 3 months2017-11-01 to 2018-01-31 | $13.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2017-05-01 to 2018-01-31 | $28.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-11-01 to 2018-01-31 | −$2.9m | us-gaap:GrossProfit |
| Gross profit | 9 months2017-05-01 to 2018-01-31 | $3.9m | us-gaap:GrossProfit |
| Research and development | 3 months2017-11-01 to 2018-01-31 | $1.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2017-05-01 to 2018-01-31 | $5.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-11-01 to 2018-01-31 | $2.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2017-05-01 to 2018-01-31 | $7.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-11-01 to 2018-01-31 | −$7.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2017-05-01 to 2018-01-31 | −$9.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-11-01 to 2018-01-31 | $19.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2017-05-01 to 2018-01-31 | $61.0k | us-gaap:InterestExpense |
| Income tax | 3 months2017-11-01 to 2018-01-31 | $2.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2017-05-01 to 2018-01-31 | $2.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-11-01 to 2018-01-31 | −$10.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2017-05-01 to 2018-01-31 | −$11.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-11-01 to 2018-01-31 | −$1.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2017-05-01 to 2018-01-31 | −$1.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-11-01 to 2018-01-31 | −$1.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2017-05-01 to 2018-01-31 | −$1.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-11-01 to 2018-01-31 | 8,846,083 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2017-05-01 to 2018-01-31 | 8,835,685 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2017-05-01 to 2018-01-31 | $4.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2017-05-01 to 2018-01-31 | $1.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-01-31 | $7.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-01-31 | $62.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-01-31 | $104.3m | us-gaap:Assets |
| Current liabilities | At period end2018-01-31 | $8.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-01-31 | $25.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-01-31 | $78.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001185185-18-000457. Last ingested by Listed: Nov 5, 2026, 18:05 ET. Listed shows no prices and gives no investment advice.